Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression

T Nechiporuk1, D P Huynh, K Figueroa

  • 1Rose Moss Laboratory for Parkinson's and Neurodegenerative Diseases, CSMC Burns and Allen Research Institute and Division of Neurology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA.

Human Molecular Genetics
|July 21, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cxcl14 chemokine defines pioneer axon guidance and early circuit assembly in the inner ear.

bioRxiv : the preprint server for biology·2026
Same author

Systemic Juvenile Idiopathic Arthritis in two children; case report on clinical course, challenges in diagnosis and the role of FDG-PET/CT-scan.

Clinical case reports·2022
Same author

Estimation of life expectancy of patients diagnosed with the most common cancers in the Valparaiso Region, Chile.

Ecancermedicalscience·2017
Same author

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

Diabetes, obesity & metabolism·2014
Same author

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Cerebellum (London, England)·2013
Same author

In Vitro Cytotoxic Effects of Dibromodulcitol in 9L Rat Brain Tumor Cells.

Pharmaceutical research·2013

Spinocerebellar ataxia type 2 (SCA2) results from a gene expansion. Researchers characterized the mouse SCA2 gene, finding it highly conserved but lacking the polyglutamine tract, suggesting a different normal function.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disorder linked to CAG trinucleotide repeat expansions in the human SCA2 gene.
  • The function of the SCA2 gene and its protein product, ataxin 2, remains largely unknown.
  • Understanding the conserved domains and normal function of SCA2 is crucial for elucidating SCA2 pathogenesis.

Purpose of the Study:

  • To isolate and characterize the mouse homolog of the human SCA2 gene.
  • To investigate conserved domains and potential functional differences between human and mouse SCA2.
  • To gain insights into the molecular mechanisms underlying SCA2.

Main Methods:

  • Sequence and amino acid analysis of the mouse SCA2 gene.

Related Experiment Videos

  • Northern blot analysis to determine gene expression patterns in various mouse tissues and during embryogenesis.
  • Immunohistochemical staining to localize ataxin 2 expression within the central nervous system (CNS).

    • Main Results:

    • The mouse SCA2 gene shares high sequence (89%) and amino acid (91%) identity with its human counterpart.
    • The mouse SCA2 cDNA lacks an extended polyglutamine tract, unlike the human gene.
    • Mouse SCA2 is expressed in most tissues, with conserved alternative splicing and early embryonic expression (E8).
    • Ataxin 2 is found in the cytoplasm of Purkinje cells and other CNS neurons.

    Conclusions:

    • The high conservation suggests a critical role for the SCA2 gene.
    • The absence of a polyglutamine tract in mouse SCA2 implies its normal function is not dependent on this domain.
    • Ataxin 2 is expressed in key neuronal populations, highlighting its potential involvement in neuronal function and development.